Drug Shortage Report for TEVA-CHLOROQUINE

Last updated on 2020-07-10 History
Report ID 99447
Drug Identification Number 00021261
Brand name TEVA-CHLOROQUINE
Common or Proper name CHLOROQUINE 250MG TABLETS
Company Name TEVA CANADA LIMITED
Market Status DORMANT
Active Ingredient(s) CHLOROQUINE DIPHOSPHATE
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code P01BA
ATC description ANTIMALARIALS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2019-11-21
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-07-10
Company comments Need to source and validate an alternate API Supplier
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-07-10 French Compare
v4 2020-07-10 English Compare
v3 2019-11-22 English Compare
v2 2019-11-21 French Compare
v1 2019-11-21 English Compare